Shanghai Rendu Biotechnology Co., Ltd. engages in the research, development, production, and sales of molecular diagnostic reagents products and supporting equipment in China and internationally. Its products are used in various therapeutic areas, including reproductive tract, respiratory tract, enterovirus infections, and bloodborne infectious diseases, as well as tumor auxiliary diagnosis. The company was founded in 2007 and is based in Shanghai, China.
Frequently asked questions
What sector does Shanghai Rendu Biotechnology Co. Ltd. A (688193) operate in?
Shanghai Rendu Biotechnology Co. Ltd. A belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Shanghai Rendu Biotechnology Co. Ltd. A (688193) current stock price?
As of the latest data, Shanghai Rendu Biotechnology Co. Ltd. A stock price is CN¥49.10, with a previous close of CN¥49.18. Shanghai Rendu Biotechnology Co. Ltd. A lost -CN¥0.08 in the last trading session, representing a -0.16% loss.
What is Shanghai Rendu Biotechnology Co. Ltd. A (688193) current market capitalization?
Shanghai Rendu Biotechnology Co. Ltd. A market cap is approximately 1.97 billion.
What is Shanghai Rendu Biotechnology Co. Ltd. A (688193) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.47.
What is Shanghai Rendu Biotechnology Co. Ltd. A (688193) Price-to-Earnings (P/E) ratio?
Shanghai Rendu Biotechnology Co. Ltd. A current P/E ratio is 104.47.
Does Shanghai Rendu Biotechnology Co. Ltd. A (688193) pay dividends?
Yes. Shanghai Rendu Biotechnology Co. Ltd. A pays semiannual dividends with an annualized yield of 4.07% and an estimated annual payout of CN¥2.00 per share.
When is the next ex-dividend date for Shanghai Rendu Biotechnology Co. Ltd. A (688193)?
The next ex-dividend date is scheduled for December 10, 2026.
What is Shanghai Rendu Biotechnology Co. Ltd. A (688193) beta (volatility) score?
Shanghai Rendu Biotechnology Co. Ltd. A has a beta of 0.361, indicating lower volatility than the overall market.
